NEW YORK ( TheStreet) -- Conceptus (Nasdaq: CPTS) hit a new 52-week low Friday as it is currently trading at $11.95, below its previous 52-week low of $11.99 with 178,924 shares traded as of 11 a.m. ET. Average volume has been 231,800 shares over the past 30 days. Conceptus has a market cap of $375.8 million and is part of the health care sector and health services industry. Shares are down 13% year to date as of the close of trading on Thursday. Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. It offers Essure, a permanent birth control system for women. The company has a P/E ratio of 4.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
Practice your CPTS trading strategies and win cash in our stock game.
TheStreet Ratings rates Conceptus as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. You can view the full Conceptus Ratings Report. See all 52-week low stocks or get investment ideas from our investment research center.